rss
Evid Based Nurs 12:76 doi:10.1136/ebn.12.3.76
  • Treatment

Review: inhaled corticosteroids do not reduce mortality but increase pneumonia in chronic obstructive pulmonary disease

QUESTION

In patients with stable chronic obstructive pulmonary disease (COPD), what are the harms and benefits of inhaled corticosteroid (ICS) therapy?

REVIEW SCOPE

Included studies compared an ICS with placebo or other inhaled medications in patients ⩾40 years of age with stable COPD. Outcomes were all-cause mortality at 1 and 3 years, pneumonia, and fractures.

REVIEW METHODS

Medline, EMBASE/Excerpta Medica, Cochrane Central Register of Controlled Trials, CINAHL, Web of Science, and PsycINFO (to Feb 2008); and references were searched for published, double-blind, randomised controlled trials (RCTs) with duration ⩾6 months. 11 RCTs (14 comparisons, n = 14 426) met the selection criteria. 8 comparisons were placebo controlled; most other trials compared an ICS plus a long-acting β2 agonist (LABA) with the LABA …

No Related Web Pages

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EBN.
View free sample issue >>

EBN Journal Chat

The EBN Journal Chat offers readers the opportunity to participate in discussion about research articles and commentaries from Evidence Based Nursing (EBN).

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article